Logo image of GRPN

GROUPON INC (GRPN) Stock Fundamental Analysis

NASDAQ:GRPN - US3994732069 - Common Stock

26.25 USD
+0.09 (+0.34%)
Last: 8/26/2025, 8:00:01 PM
26.25 USD
0 (0%)
After Hours: 8/26/2025, 8:00:01 PM
Fundamental Rating

2

GRPN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 28 industry peers in the Broadline Retail industry. Both the profitability and financial health of GRPN have multiple concerns. GRPN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

GRPN had negative earnings in the past year.
GRPN had a positive operating cash flow in the past year.
In the past 5 years GRPN reported 4 times negative net income.
GRPN had negative operating cash flow in 4 of the past 5 years.
GRPN Yearly Net Income VS EBIT VS OCF VS FCFGRPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

GRPN's Return On Assets of -1.42% is in line compared to the rest of the industry. GRPN outperforms 42.86% of its industry peers.
Looking at the Return On Equity, with a value of -17.99%, GRPN is doing worse than 71.43% of the companies in the same industry.
The Return On Invested Capital of GRPN (0.77%) is worse than 64.29% of its industry peers.
Industry RankSector Rank
ROA -1.42%
ROE -17.99%
ROIC 0.77%
ROA(3y)-16.43%
ROA(5y)-11.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRPN Yearly ROA, ROE, ROICGRPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

GRPN's Operating Margin of 0.57% is on the low side compared to the rest of the industry. GRPN is outperformed by 64.29% of its industry peers.
In the last couple of years the Operating Margin of GRPN has declined.
GRPN has a better Gross Margin (90.58%) than 100.00% of its industry peers.
GRPN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.57%
PM (TTM) N/A
GM 90.58%
OM growth 3Y-37.22%
OM growth 5Y-11.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.78%
GM growth 5Y11.03%
GRPN Yearly Profit, Operating, Gross MarginsGRPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

2

2. Health

2.1 Basic Checks

GRPN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GRPN has been increased compared to 1 year ago.
The number of shares outstanding for GRPN has been increased compared to 5 years ago.
Compared to 1 year ago, GRPN has an improved debt to assets ratio.
GRPN Yearly Shares OutstandingGRPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GRPN Yearly Total Debt VS Total AssetsGRPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -1.40, we must say that GRPN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.40, GRPN is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
The Debt to FCF ratio of GRPN is 3.80, which is a good value as it means it would take GRPN, 3.80 years of fcf income to pay off all of its debts.
GRPN has a better Debt to FCF ratio (3.80) than 60.71% of its industry peers.
A Debt/Equity ratio of 4.17 is on the high side and indicates that GRPN has dependencies on debt financing.
With a Debt to Equity ratio value of 4.17, GRPN is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF 3.8
Altman-Z -1.4
ROIC/WACC0.09
WACC8.18%
GRPN Yearly LT Debt VS Equity VS FCFGRPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

GRPN has a Current Ratio of 0.96. This is a bad value and indicates that GRPN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of GRPN (0.96) is worse than 89.29% of its industry peers.
A Quick Ratio of 0.96 indicates that GRPN may have some problems paying its short term obligations.
The Quick ratio of GRPN (0.96) is worse than 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
GRPN Yearly Current Assets VS Current LiabilitesGRPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for GRPN have decreased strongly by -117.65% in the last year.
Looking at the last year, GRPN shows a decrease in Revenue. The Revenue has decreased by -4.72% in the last year.
GRPN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -25.99% yearly.
EPS 1Y (TTM)-117.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1700%
Revenue 1Y (TTM)-4.72%
Revenue growth 3Y-20.14%
Revenue growth 5Y-25.99%
Sales Q2Q%0.87%

3.2 Future

Based on estimates for the next years, GRPN will show a very strong growth in Earnings Per Share. The EPS will grow by 46.06% on average per year.
The Revenue is expected to grow by 12.84% on average over the next years. This is quite good.
EPS Next Y132.19%
EPS Next 2Y62.77%
EPS Next 3Y46.06%
EPS Next 5YN/A
Revenue Next Year3.27%
Revenue Next 2Y6.81%
Revenue Next 3Y9.35%
Revenue Next 5Y12.84%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GRPN Yearly Revenue VS EstimatesGRPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
GRPN Yearly EPS VS EstimatesGRPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

GRPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 33.14, the valuation of GRPN can be described as expensive.
GRPN's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of GRPN to the average of the S&P500 Index (22.67), we can say GRPN is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 33.14
GRPN Price Earnings VS Forward Price EarningsGRPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

GRPN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GRPN is more expensive than 67.86% of the companies in the same industry.
67.86% of the companies in the same industry are more expensive than GRPN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.34
EV/EBITDA 40.05
GRPN Per share dataGRPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GRPN's earnings are expected to grow with 46.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.77%
EPS Next 3Y46.06%

0

5. Dividend

5.1 Amount

GRPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GROUPON INC

NASDAQ:GRPN (8/26/2025, 8:00:01 PM)

After market: 26.25 0 (0%)

26.25

+0.09 (+0.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-10 2025-11-10
Inst Owners57.57%
Inst Owner Change16.08%
Ins Owners2.68%
Ins Owner Change4.98%
Market Cap1.06B
Analysts78
Price Target34.17 (30.17%)
Short Float %40.68%
Short Ratio6.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2534.48%
Min EPS beat(2)265.44%
Max EPS beat(2)4803.53%
EPS beat(4)3
Avg EPS beat(4)632.5%
Min EPS beat(4)-2841.18%
Max EPS beat(4)4803.53%
EPS beat(8)4
Avg EPS beat(8)190.36%
EPS beat(12)7
Avg EPS beat(12)133.3%
EPS beat(16)9
Avg EPS beat(16)125.86%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)0.63%
Revenue beat(8)4
Avg Revenue beat(8)-0.89%
Revenue beat(12)5
Avg Revenue beat(12)-2.95%
Revenue beat(16)5
Avg Revenue beat(16)-3.31%
PT rev (1m)11.67%
PT rev (3m)81.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-63.65%
EPS NY rev (1m)-3.75%
EPS NY rev (3m)-20.34%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)-0.43%
Revenue NY rev (1m)1.25%
Revenue NY rev (3m)1.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.14
P/S 2.18
P/FCF 16.34
P/OCF 13.42
P/B 20.73
P/tB N/A
EV/EBITDA 40.05
EPS(TTM)-0.37
EYN/A
EPS(NY)0.79
Fwd EY3.02%
FCF(TTM)1.61
FCFY6.12%
OCF(TTM)1.96
OCFY7.45%
SpS12.06
BVpS1.27
TBVpS-3.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.42%
ROE -17.99%
ROCE 0.97%
ROIC 0.77%
ROICexc 8.72%
ROICexgc N/A
OM 0.57%
PM (TTM) N/A
GM 90.58%
FCFM 13.32%
ROA(3y)-16.43%
ROA(5y)-11.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-40.94%
ROICexc growth 5Y-53.59%
OM growth 3Y-37.22%
OM growth 5Y-11.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.78%
GM growth 5Y11.03%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF 3.8
Debt/EBITDA 8.17
Cap/Depr 60.69%
Cap/Sales 2.9%
Interest Coverage 0.47
Cash Conversion 302.95%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z -1.4
F-Score6
WACC8.18%
ROIC/WACC0.09
Cap/Depr(3y)52%
Cap/Depr(5y)57.82%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1700%
EPS Next Y132.19%
EPS Next 2Y62.77%
EPS Next 3Y46.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.72%
Revenue growth 3Y-20.14%
Revenue growth 5Y-25.99%
Sales Q2Q%0.87%
Revenue Next Year3.27%
Revenue Next 2Y6.81%
Revenue Next 3Y9.35%
Revenue Next 5Y12.84%
EBIT growth 1Y-88.07%
EBIT growth 3Y-49.87%
EBIT growth 5Y-34.77%
EBIT Next Year895.54%
EBIT Next 3Y158.56%
EBIT Next 5Y131.3%
FCF growth 1Y137.26%
FCF growth 3YN/A
FCF growth 5Y188.49%
OCF growth 1Y154.1%
OCF growth 3YN/A
OCF growth 5Y-4.75%